Acne as a chronic systemic disease

Gollnick, 2008, Can we define acne as a chronic disease? If so, how and when?, Am J Clin Dermatol, 9, 279, 10.2165/00128071-200809050-00001 Zouboulis, 2001, Is acne vulgaris a genuine inflammatory disease?, Dermatology, 203, 277, 10.1159/000051771 Zouboulis, 2004, Acne and sebaceous gland function, Clin Dermatol, 22, 360, 10.1016/j.clindermatol.2004.03.004 Zouboulis, 2005, What is the pathogenesis of acne?, Exp Dermatol, 14, 143, 10.1111/j.0906-6705.2005.0285a.x Kurokawa, 2009, New developments in our understanding of acne pathogenesis and treatment, Exp Dermatol, 18, 821, 10.1111/j.1600-0625.2009.00890.x Zouboulis, 2009, Propionibacterium acnes and sebaceous lipogenesis: a love-hate relationship?, J Invest Dermatol, 129, 2093, 10.1038/jid.2009.190 Frost, 1972, Inhibitors of sex hormones: development of experimental models, Adv Biol Skin, 12, 403 Guy, 1993, Isolation and maintenance of the human pilosebaceous duct: 13-cis retinoic acid acts directly on the duct in vitro, Br J Dermatol, 128, 242, 10.1111/j.1365-2133.1993.tb00165.x Guy, 1996, The improved organ maintenance of the human sebaceous gland: modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis retinoic acid, and phenol red, J Invest Dermatol, 106, 454, 10.1111/1523-1747.ep12343608 Zouboulis, 1998, The human sebocyte culture model provides new insights into development and management of seborrhea and acne, Dermatology, 196, 21, 10.1159/000017861 Mirshahpanah, 2007, Models in acnegenesis, Cutan Ocul Toxicol, 26, 195, 10.1080/15569520701502815 Nakatsuji, 2008, Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris, J Invest Dermatol, 128, 2451, 10.1038/jid.2008.117 Xia, 1989, Isolation of human sebaceous glands and cultivation of sebaceous gland-derived cells as an in vitro model, J Invest Dermatol, 93, 315, 10.1111/1523-1747.ep12280234 Zouboulis, 2008, The sebocyte culture: A model to study the pathophysiology of the sebaceous gland in sebostasis, seborrhea and acne, Arch Dermatol Res, 300, 397, 10.1007/s00403-008-0879-5 Zouboulis, 1999, Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95), J Invest Dermatol, 113, 1011, 10.1046/j.1523-1747.1999.00771.x Centers for Disease Control. “Classifications of diseases and functioning and disability”. In: Classifications of Diseases and Functioning and Disability. Definition of Disability Reference. National Center for Health Statistics; 2001. O'Halloran, 2004, Defining chronic conditions for primary care with ICPC-2, Fam Pract, 21, 381, 10.1093/fampra/cmh407 Cunliffe, 1986, Acne and unemployment, Br J Dermatol, 115, 386, 10.1111/j.1365-2133.1986.tb05757.x Goulden, 1999, The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals, Br J Dermatol, 141, 297, 10.1046/j.1365-2133.1999.02979.x James, 2005, Clinical practice. Acne, N Engl J Med, 352, 1463, 10.1056/NEJMcp033487 Kellett, 1999, The psychological and emotional impact of acne and the effect of treatment with isotretinoin, Br J Dermatol, 140, 273, 10.1046/j.1365-2133.1999.02662.x Niemeier, 1998, Coping with acne vulgaris. Evaluation of the chronic skin disorder questionnaire in patients with acne, Dermatology, 196, 108, 10.1159/000017842 Tan, 2004, The Canadian acne epidemiologic survey: baseline demographics and interim analysis, J Am Acad Dermatol, 50, 15, 10.1016/j.jaad.2003.10.062 Thiboutot, 1995, Acne: acute or chronic disease?, J Am Acad Dermatol, 32, S2, 10.1016/0190-9622(95)90414-X Thiboutot, 2009, New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group, J Am Acad Dermatol, 60, S1, 10.1016/j.jaad.2009.01.019 Collier, 2008, The prevalence of acne in adults 20 years and older, J Am Acad Dermatol, 58, 56, 10.1016/j.jaad.2007.06.045 Dreno, 2013, Adult female acne: a new paradigm, J Eur Acad Dermatol Venereol, 27, 1063, 10.1111/jdv.12061 Goulden, 1999, Prevalence of facial acne in adults, J Am Acad Dermatol, 41, 577 Poli, 2001, An epidemiologic study of acne in female adults: results of a survey conducted in France, J Eur Acad Dermatol Venereol, 15, 541, 10.1046/j.1468-3083.2001.00357.x Chen, 2011, Acne-associated syndromes: models for better understanding of acne pathogenesis, J Eur Acad Dermatol Venereol, 25, 637, 10.1111/j.1468-3083.2010.03937.x Dessinioti, 2009, Congenital adrenal hyperplasia, Dermatoendocrinol, 1, 87, 10.4161/derm.1.2.7818 Trakakis, 2010, An update to 21-hydroxylase deficient congenital adrenal hyperplasia, Gynecol Endocrinol, 26, 63, 10.3109/09513590903015494 New, 2004, An update of congenital adrenal hyperplasia, Ann N Y Acad Sci, 1038, 14, 10.1196/annals.1315.009 Speiser, 2003, Congenital adrenal hyperplasia, N Engl J Med, 349, 776, 10.1056/NEJMra021561 Witchel, 2013, Nonclassic congenital adrenal hyperplasia, Steroids, 78, 747, 10.1016/j.steroids.2013.04.010 Caputo, 2010, Refractory acne and 21-hydroxylase deficiency in a selected group of female patients, Dermatology, 220, 121, 10.1159/000277608 Trakakis, 2008, The prevalence of non-classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Greek women with hirsutism and polycystic ovary syndrome, Endocr J, 55, 33, 10.1507/endocrj.K07-053 Zouboulis, 2003, Update and future of systemic acne treatment, Dermatology, 206, 37, 10.1159/000067821 Orfanos, 1982, Antiandrógenos en dermatología, Arch Arg Derm, 32, 51 Orfanos, 2000, The SAHA syndrome, Horm Res, 54, 251, 10.1159/000053267 Zouboulis, 2007, Sexual hormones in human skin, Horm Metab Res, 39, 85, 10.1055/s-2007-961807 Lowenstein, 2006, Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome, Dermatol Ther, 19, 210, 10.1111/j.1529-8019.2006.00077.x Carmina, 2006, Mild androgen phenotypes, Best Pract Res Clin Endocrinol Metab, 20, 207, 10.1016/j.beem.2006.02.001 Chen, 2009, Hormones and the pilosebaceous unit, Dermatoendocrinol, 1, 81, 10.4161/derm.1.2.8354 Carmina, 2006, Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism, J Clin Endocrinol Metab, 91, 2, 10.1210/jc.2005-1457 Zouboulis, 2010, Hormonal antiandrogens in acne treatment, J Dtsch Dermatol. Ges, 8, S60, 10.1111/j.1610-0387.2009.07171.x Witchel, 2012, Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome, Endocrine, 42, 526, 10.1007/s12020-012-9701-4 Ewens, 2010, Family-based analysis of candidate genes for polycystic ovary syndrome, J Clin Endocrinol Metab, 95, 2306, 10.1210/jc.2009-2703 Deligeoroglou, 2009, The role of genes in the polycystic ovary syndrome: predisposition and mechanisms, Gynecol Endocrinol, 25, 603, 10.1080/09513590903015619 Wehr, 2010, Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndrome, Metabolism, 59, 575, 10.1016/j.metabol.2009.08.023 Adler, 2000, Eine seltene Variante des SAHA Syndroms, Z Hautkr, 76, 327 Rager, 2006, Androgen excess disorders in women: the severe insulin-resistant hyperandrogenic syndrome, HAIR-AN, Sci World J, 6, 116, 10.1100/tsw.2006.23 Makrantonaki, 2008, Interplay of IGF-I and 17beta-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro, Exp Gerontol, 43, 939, 10.1016/j.exger.2008.07.005 Blomberg, 2010, FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature, Dermatology, 220, 297, 10.1159/000297575 Chamot, 1986, Acute pseudoseptic arthritis and palmoplantar pustulosis, Clin Rheumatol, 5, 118, 10.1007/BF02030980 Hayem, 1999, SAPHO syndrome: a long-term follow-up study of 120 cases, Semin Arthritis Rheum, 29, 159, 10.1016/S0049-0172(99)80027-4 Kahn, 1994, The SAPHO syndrome, Baillieres Clin Rheumatol, 8, 333, 10.1016/S0950-3579(94)80022-7 Kahn, 1991, Sternoclavicular pustulotic osteitis (SAPHO). 20-year interval between skin and bone lesions, J Rheumatol, 18, 1104 Hurtado-Nedelec, 2008, Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome, Rheumatology (Oxford), 47, 1160, 10.1093/rheumatology/ken185 Olivieri, 2006, Pharmacological management of SAPHO syndrome, Expert Opin Investig Drugs, 15, 1229, 10.1517/13543784.15.10.1229 Lindor, 1997, A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome, Mayo Clin Proc, 72, 611, 10.1016/S0025-6196(11)63565-9 Wise, 2002, Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder, Hum Molec Genet, 11, 961, 10.1093/hmg/11.8.961 Kanazawa, 2007, Autoinflammatory syndromes with a dermatological perspective, J Dermatol, 34, 601, 10.1111/j.1346-8138.2007.00342.x Dierselhuis, 2005, Anakinra for flares of pyogenic arthritis in PAPA syndrome, Rheumatology (Oxford), 44, 406, 10.1093/rheumatology/keh479 Apert, 1906, De l`a acrocéphalosyndactylie, Bull Soc Med Hop (Paris), 23, 1310 Boulet, 2008, A population-based study of craniosynostosis in metropolitan Atlanta, 1989–2003, Am J Med Genet A, 146A, 984, 10.1002/ajmg.a.32208 Solomon, 1970, Pilosebaceous abnormalities in Apert's syndrome, Arch Dermatol, 102, 381, 10.1001/archderm.1970.04000100029007 Melnik, 2009, Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris, Exp Dermatol, 18, 833, 10.1111/j.1600-0625.2009.00924.x Wilkie, 1995, Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome, Nat Genet, 9, 165, 10.1038/ng0295-165 Melnik, 2009, Role of FGFR2-signaling in the pathogenesis of acne, Dermatoendocrinol, 1, 141, 10.4161/derm.1.3.8474 Melnik, 2010, FoxO1-the key for the pathogenesis and therapy of acne?, J Dtsch Dermatol Ges, 8, 105 Melnik, 2010, Is nuclear deficiency of FoxO1 due to increased growth factor/PI3K/Akt-signalling in acne vulgaris reversed by isotretinoin treatment?, Br J Dermatol, 162, 1398, 10.1111/j.1365-2133.2010.09754.x Letawe, 1998, Digital image analysis of the effect of topically applied linoleic acid on acne microcomedones, Clin Exp Dermatol, 23, 56, 10.1046/j.1365-2230.1998.00315.x Alestas, 2006, Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands, J Mol Med (Berl), 84, 75, 10.1007/s00109-005-0715-8 Wrobel, 2003, Differentiation and apoptosis in human immortalized sebocytes, J Invest Dermatol, 120, 175, 10.1046/j.1523-1747.2003.12029.x Zouboulis, 2003, A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor, Arch Dermatol, 139, 668, 10.1001/archderm.139.5.668 Steiner, 1946, Necropsies on Okinawans; anatomic and pathologic observations, Arch Pathol (Chic), 42, 359 Simopoulos, 2001, Evolutionary aspects of diet and essential fatty acids, World Rev Nutr Diet, 88, 18, 10.1159/000059742 Cordain, 2002, Acne vulgaris: a disease of Western civilization, Arch Dermatol, 138, 1584, 10.1001/archderm.138.12.1584 Thiboutot, 2002, Diet and acne revisited, Arch Dermatol, 138, 1591, 10.1001/archderm.138.12.1591 Thielitz, 2007, Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation, J Invest Dermatol, 127, 1042, 10.1038/sj.jid.5700439